Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05949242 · ClinicalTrials.gov registry record · NA
Clinical Outcomes in Cataract Surgery With OMNI Canaloplasty vs Cataract Surgery With OMNI Canaloplasty and Hydrus Stent
A NA study of Glaucoma Open-Angle, sponsored by Ridge Eye Care.
- Active
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 4
- Study locations
NCT05949242: Active NA study of Glaucoma Open-Angle, sponsored by Ridge Eye Care.
NCT05949242 is a NA study of Glaucoma Open-Angle that is active but no longer recruiting, run by Ridge Eye Care. The registered enrollment target is 80 participants, below the 162-participant average among 22 other Glaucoma Open-Angle trials with a reported enrollment target (51% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05949242, a NA study of Glaucoma Open-Angle, is active but no longer recruiting, sponsored by Ridge Eye Care.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this clinical trial is to look at the difference in pressure lowering effects in patients having two different combinations of minimally invasive glaucoma surgery (MIGS) at the time of their cataract surgery. Eligible patients will have mild to moderate glaucoma and be candidates for cataract surgery. The trial will look at the eye pressure before and one year after cataract surgery in patients. One eye in each patient will have cataract surgery with canaloplasty using OMNI. The patients other eye will have cataract surgery with canaloplasty and a HYDRUS stent. The trial will look at the differences in eye pressure and if patients are able to need fewer eye pressure lowering drops after surgery. Study participants will undergo preop testing of pressure, vision, slit lamp exam, ocular coherence tomography (OCT) of the nerve fiber layer (NFL) analysis, and visual field prior to cataract surgery with MIGS. One day, one week, one month, 6 month, and 1 year exams will be performed to check pressure, vision, slit lamp exam, and number of necessary eye pressure medications in each eye.
Primary Outcome
check intraocular pressure at start date and at 12 months after washout of all pressure controlling drops
Conditions Studied
Interventions
- DEVICE OMNI canaloplasty
- DEVICE Hydrus microstent
Study Locations (4)
California
- Royo Eye Care - Marysville
- Table Mountain Eye Care - Oroville
- Ridge Eye Institute - Paradise
- Feather River Eye Care - Yuba City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-04-07 |
| Est. Completion | 2025-10 |
| Phase | NA |
What the registry record for NCT05949242 still lists
NCT05949242 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 162-participant average among 22 other Glaucoma Open-Angle trials with a reported enrollment target (51% lower).
The record links to 1 condition, with Glaucoma Open-Angle appearing as the primary indexed condition, and to 2 interventions - of which OMNI canaloplasty is the first listed.
NCT05949242 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05949242 about?
NCT05949242 is a clinical study titled "Clinical Outcomes in Cataract Surgery With OMNI Canaloplasty vs Cataract Surgery With OMNI Canaloplasty and Hydrus Stent". The goal of this clinical trial is to look at the difference in pressure lowering effects in patients having two different combinations of minimally invasive glaucoma surgery (MIGS) at the time of their cataract surgery. Eligible patients will have mild to moderate glaucoma and be candidates for cat...
What is the current status of trial NCT05949242?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-04-07. Estimated completion is 2025-10.
What conditions does trial NCT05949242 study?
This clinical trial studies the following conditions: Glaucoma Open-Angle.
What interventions are being tested in trial NCT05949242?
The interventions under investigation include: OMNI canaloplasty (DEVICE), Hydrus microstent (DEVICE).
Who is sponsoring clinical trial NCT05949242?
This trial is sponsored by Ridge Eye Care, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05949242 being conducted?
This trial has 4 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma Open-Angle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05949242's enrollment target sits among peer trials
80 13th of 22 higher than 10 of 22 other Glaucoma Open-Angle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma Open-Angle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Electrical Stimulation for Vision Neuroenhancement in Glaucoma
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Optic Neuropathies
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Glaucoma
RECRUITING · NA
-
Optic Nerve Head Strain as Biomarker for Glaucoma
RECRUITING · NA
-
Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery
RECRUITING · NA
-
A Trial of Hydrus Microstent Versus Goniotomy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI